Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Aln-cc5	-	-	-	-	[3] 62, 66, 109 💬
2	Alxn1210	-	-	-	-	[5]  2 , 11, 13, 62, 109 💬
3	Anti-c5 antibody	-	-	-	-	[4] 11, 14, 62, 109 💬
4	Ccx168	-	-	-	-	[6] 43, 44, 66, 109, 222, 223 💬
5	Cemdisiran	Cemdisiran	-	-	-	[2] 66, 109 💬
6	Coversin	Nomacopan	[1] D11473 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[2] 62, 109 💬
7	Eculizumab	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[8] 11, 13, 14, 61, 62, 109, 222, 223 💬
8	Fc- and cdr-modified humanised monoclonal antibody against c5	-	-	-	-	[3] 11, 62, 109 💬
9	Igg2/4?	-	-	-	-	[1] 109 💬
10	Masp-2 antibody	Narsoplimab	[1] D11531 💬	[1] MASP2 💬	[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection	[2] 64, 109 💬
11	Oms00620646, oms620646, masp-2 antibody	Narsoplimab	[1] D11531 💬	[1] MASP2 💬	[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection	[1] 109 💬
12	Oms721	-	-	-	-	[3] 64, 66, 109 💬
13	Oms721 100 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody	Narsoplimab	[1] D11531 💬	[1] MASP2 💬	[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection	[2] 64, 109 💬
14	Oms721 185 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody	Narsoplimab	[1] D11531 💬	[1] MASP2 💬	[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection	[2] 64, 109 💬
15	Oms721 drug product 185 mg/ml	-	-	-	-	[1] 109 💬
16	Other: eculizumab	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[1] 109 💬
17	Ravulizumab	Ravulizumab	[1] D11054 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[5]  2 , 11, 13, 62, 109 💬
18	Rva576	-	-	-	-	[3] 62, 109, 162 💬
19	Rva576 (coversin)	Nomacopan	[1] D11473 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[2] 62, 109 💬
20	Solaris	-	-	-	-	[1] 109 💬
21	Soliris	-	-	-	-	[7] 11, 13, 14, 61, 62, 109, 222 💬
22	Soliris - 300 mg concentrato per soluzione per infusione - uso endovenoso 1 flaconcino (vetro) 30 ml (10 mg/ml)	-	-	-	-	[1] 109 💬
23	Soliris 300 mg concentrado para solución para perfusión	-	-	-	-	[1] 109 💬

Back to top